scPharmaceuticals Inc. (SCPH) Misses Q1 EPS by 4c

scPharmaceuticals Inc. (NASDAQ: SCPH) reported Q1 EPS of ($0.36), $0.04 worse than the analyst estimate of ($0.32). Revenue for the quarter came in at $11.8 million versus the consensus estimate of $12.83 million.

For earnings history and earnings-related data on scPharmaceuticals Inc. (SCPH) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• William Blair Downgrades Enovix Corporation (ENVX) to Market Perform
• UBS: 'We Believe Dollar Tree (DLTR) is Turning From a Transformation to a Growth Story'